Alivus Life Sciences Ltd.

The company's total revenue for the quarter ended December 2021 saw a slight change in the total revenue, having registered a total revenue of Rs. 5224.99 millions.A humble growth in net profit of 11.09% reported in the quarter ended December 2021 to Rs. 1037.13  millions from Rs. 933.61 millions.A decline of 1495.98 millions was observed in the OP in the quarter ended December 2021 from 1552.00 millions on QoQ basis.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202112	202012	% Var	202112	202012	% Var	202112	202012	% Var
Sales	5224.99	5002.29	4.45	5224.99	5002.29	4.45	5224.99	5002.29	4.45
Other Income	35.34	3.72	850.00	35.34	3.72	850.00	35.34	3.72	850.00
PBIDT	1495.98	1552.00	-3.61	1495.98	1552.00	-3.61	1495.98	1552.00	-3.61
Interest	0.61	216.50	-99.72	0.61	216.50	-99.72	0.61	216.50	-99.72
PBDT	1495.37	1335.50	11.97	1495.37	1335.50	11.97	1495.37	1335.50	11.97
Depreciation	97.39	83.60	16.50	97.39	83.60	16.50	97.39	83.60	16.50
PBT	1397.98	1251.90	11.67	1397.98	1251.90	11.67	1397.98	1251.90	11.67
TAX	360.85	318.29	13.37	360.85	318.29	13.37	360.85	318.29	13.37
Deferred Tax	41.49	20.78	99.66	41.49	20.78	99.66	41.49	20.78	99.66
PAT	1037.13	933.61	11.09	1037.13	933.61	11.09	1037.13	933.61	11.09
Equity	245.05	19.60	1150.26	245.05	19.60	1150.26	245.05	19.60	1150.26
PBIDTM(%)	28.63	31.03	-7.72	28.63	31.03	-7.72	28.63	31.03	-7.72